In Deusa Cast #54, Marco Fiaschetti advocates for treatment customization and the inclusion of the compounding model in the revision of RDC 327

New resolution allows planting by universities and pharmaceutical industries, requiring maximum security systems and total traceability of the plant

Proposal aims to regulate the performance of non-profit entities in a controlled experimental environment, using the Regulatory Sandbox model to comply with STJ decision

Survey indicates that 3.7% of the adult population in the United States reported using subperceptual doses of psychedelics in the last year

The Caribbean island's Parliament has approved legislative amendments allowing limited possession and home cultivation for individuals over 21 years old

New research relies on rigorous methodologies, such as double-blind studies, and investigates the potential of lesser-known cannabinoids, such as CBG and THCV

Dr. Jimmy Fardim and Dr. Rafaela da Rosa explain how microbiota, endocannabinoid system, and cannabis connect in building truly integrative health

Review of the standard may limit imports via RDC 660 if there is a national equivalent; director Thiago Campos presents his point of view

Scientific Committee maintains technical rigor and focuses on a forward-looking program in the 5th edition of the event in São Paulo

Research published in Sleep Medicine: X reveals that the herbal remedy improves sleep quality and quality of life with safety similar to benzodiazepines

Bill under review in Delaware may allow the use of medical cannabis in hospitals by terminal patients, with specific safety and storage rules

Regulatory grant protects Farm Gas™ and Sourdough™ genetics and ensures company's commercial control over its strains

Botswana has published new rules for cannabis, with THC limits, strict licenses, and control over cultivation, transportation, research, and export

Experts warn that lack of preparation, professional guidance, and post-session support can compromise the safety and outcomes of psychedelic therapy

"Tempo Bom" work combines science and Northeastern popular culture; project will raise funds to address the use of medical cannabis in Brazil

CONICET study suggests that cannabidiol (CBD) may enhance the action of antibiotics in combating resistant bacteria in laboratory tests

Cannabis sales in Michigan hit a record high in 2025, but a drop in prices reduces the sector's revenue, according to state market data

Lecture led by specialist will address scientific updates, clinical use, and regulation of cannabinoid therapies in Dentistry during the event in São Paulo

Patient follow-up for up to two years

Event consolidates itself as the main space for scientific, regulatory, and business updates in the sector. Secure your spot!

Event opens deadline for submission of scientific abstracts in oral presentation and poster formats

The National Narcotics Fund (FNE) will no longer require Export Certificates for shipments destined to patients (Individuals) in Brazil, eliminating a bureaucratic obstacle that hindered the flow of derivatives between the two countries

Resumption of review by Anvisa and final deadline from STJ for cultivation define the sector's direction in the first quarter of the year

Adesaf Institute points out unconstitutionality in vetoing workers with a criminal history in research areas and requests a review of the measure

Episode of Deusa Cast brings together experts to discuss therapeutic cannabis, integrative health, and the potential of hemp in medicine, dentistry, and sustainable fashion.

Study analyzed Cannabis sativa extracts rich in CBC and THC and observed cytotoxic effects on human urothelial carcinoma cells and tissues

The Spanish Supreme Court has accepted the request from pharmaceutical entities challenging the exclusivity of dispensing cannabis products only in hospitals, as determined by the recent Royal Decree

CFO supports dentists among authorized professionals to prescribe safely and with quality

USDA study identified compounds in hemp roots with activity against pediatric cancer cells, pointing to new possibilities for scientific research

President advances in the medicinal agenda and targets elderly electorate with CBD in Medicare, but signs law that threatens hemp market